Back to top

Clear Street Keeps Their Buy Rating on Summit Therapeutics (SMMT)

Clear Street analyst maintained a Buy rating on Summit Therapeutics today and set a price target of $31.00. In addition to Clear Street, Summit The...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Summit Therapeutics PLC (SMMT)